Bacteriophages for reducing toxicity of bacteria

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8865158
SERIAL NO

13477213

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A genetically modified bacteriophage is disclosed which comprises:

    (i) an exogenous polynucleotide which encodes an agent which reduces the toxicity of a bacterium; and(ii) an exogenous polynucleotide which encodes a selectable marker.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RAMOT AT TEL-AVIV UNIVERSITY LTD6139201 TEL-AVIV

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Edgar, Rotem Kfar-Saba, IL 5 113
Friedman, Nir Nes Ziona, IL 15 327
Qimron, Ehud Tel Aviv, IL 5 82

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 21, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00